exelon patch 10 (9.5mg24hr)
novartis (singapore) pte ltd - rivastigmine (as base) - patch, extended release - 18.00mg/10cm2 - rivastigmine (as base) 18.00mg/10cm2
exelon patch 5 (4.6mg24hr)
novartis (singapore) pte ltd - rivastigmine (as base) - patch, extended release - 9mg/5cm2 - rivastigmine (as base) 9mg/5cm2
exelon patch 15 (13.3mg24hr)
novartis (singapore) pte ltd - rivastigmine (as base) - patch, extended release - 27.000 mg - rivastigmine (as base) 27.000 mg
rivastigmine teva
teva pharma b.v. - rivastigmine - dementia; alzheimer disease; parkinson disease - anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.
rivastigmine 3m health care ltd
3m health care limited - rivastigmine - alzheimer disease - psychoanaleptics, , anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia.
eximine xl 4.6 mg/day transdermal patch
clonmel healthcare ltd - rivastigmine base - transdermal patch - 4.6 mg/day - anticholinesterases
eximine xl 9.5 mg/day transdermal patch
clonmel healthcare ltd - rivastigmine base - transdermal patch - 9.5 mg/day - anticholinesterases
rivastigmine teva 4.6 mg/24 hours transdermal patch
teva pharma b.v. - rivastigmine base - transdermal patch - 4.6 mg/24 hours - anticholinesterases
rivastigmine teva 9.5 mg/24 hours transdermal patch
teva pharma b.v. - rivastigmine base - transdermal patch - 9.5 mg/24 hours - anticholinesterases
exelon capsule 1.5 mg
novartis (singapore) pte ltd - rivastigmine hydrogen tartrate eqv rivastigmine - capsule - 1.5 mg - rivastigmine hydrogen tartrate eqv rivastigmine 1.5 mg